Embedded Files
Ghent University
Ghent University
Ghent University is a leading Belgian university known for its high-quality education, cutting-edge research, and strong international orientation. With a broad range of disciplines and a commitment to innovation and societal impact, it plays a key role in addressing global challenges through collaborative research and knowledge sharing.
CESPE, was established as an interfaculty partnership within the Ghent University Association and has since grown into an innovation centre with academic members from 5 faculties and multiple industrial partners. Within CESPE, the focus is on sustainable production innovation of pharmaceutical and biopharmaceutical drug products and drug substances.
Through its educational platform, CESPE Academy, the initiative already offers practice-oriented training modules for specific disciplines in the (bio)pharmaceutical value chain. CESPE Academy's offering will be expanded into PHARMAFORGE's Lifelong Learning (LLL) platform using insights gained from the project's gap analysis and knowledge generated from developments in high-throughput experimentation.
CESPE also functions as the coordinator of the PHARMAFORGE project, monitoring and reporting on its progress.
HighTru is a core facility of Ghent Univeristy that is working towards boosting the discovery of small molecule research by implementing state-of-the art high-throughput experimentation. HighTru serves as a bridge between organic synthesis, automation and artificial intelligence, by incorporating the technology reaction platforms for parallel and/or serial experiments, robotic tools for lab automation, and the appropriate informatics and IT.
Expertise and infrastructure of HighTru facilities will play a crucial role in establishing PHARMAFORGE's Open Access Labs, which will provide easier access to high-throughput experimentation in the cross-boarder region.
Princess Máxima Center
Princess Máxima Center
The Princess Máxima Center for Pediatric Oncology (PMC) is the largest pediatric oncology center in Europe, with a mission to cure every child with cancer and provide an optimal quality of life. The center treats more than 1,000 children with cancer per year and works with approximately 400 researchers and healthcare professionals. The focus is on improving survival rates and reducing side effects through scientific research and innovative treatments. The PMC plays a key role in scientific advancement in the field of pediatric oncology. The integration of care and research under one roof creates a dynamic environment where clinical expertise and scientific research reinforce each other. This accelerates the development of new, tailored therapies, which benefits not only patients but also advances the scientific community.
The High-throughput Screening Facility is a large state-of-the art robotic system of the Princess Máxima Center. This core facility enables researchers to test new drugs for pediatric cancer quickly and on a large scale, focusing on identifying effective drugs, combinations, and underlying biological targets. It provides end-to-end support, including assay development, large-scale screening, and advanced data analysis using a flexible, state-of-the-art robotic platform. This accelerates the translation of research into clinical applications, contributing to improved treatment outcomes for children with cancer. Equipped with cutting-edge instrumentation and curated drug libraries, the lab enables diverse assays and scalable experimentation with high precision and reproducibility. As a project partner, the facility will contribute to developing a combined HTE-HTS platform for direct-to-biology workflows within the PHARMAFORGE's Open Access Labs concept.
Biovia
Biovia
Biovia is the health innovation cluster of Flanders, bringing together human and planetary health in one dynamic ecosystem. It is an industry-driven membership organization spanning medical biotech, medtech, digital health, agtech and industrial biotech. As one of six spearhead clusters supported by Flanders Innovation & Entrepreneurship (VLAIO), Biovia connects over 350 members and partners, including companies, research institutes, universities, hospitals, service providers, investors and government.
The organization supports its members through funding, education, networking, representation and the development of collaborative innovation projects, helping them create health solutions and grow in Belgium and beyond. With strong, established ties to key players in the Dutch life sciences sector, Biovia plays a central role in identifying, connecting and mobilizing stakeholders across both Flanders and the Netherlands.
Biovia is responsible for the coordination and rollout of the gap analysis and also plays a crucial role in the broad dissemination of the PHARMAFORGE platform within the entire program area. Additionally, together with CESPE Academy, Biovia will contribute by attracting specialized experts from its network to develop or deliver specific training modules for the PHARMAFORGE's Lifelong Learning (LLL) platform.
Page updated
Google Sites
Report abuse